Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Human leukocyte antigen-G 3' untranslated region polymorphism +3142G/C (rs1063320) and haplotypes are associated with manifestations of the American Tegumentary Leishmaniasis in a Northeastern Brazilian population.

Sonon P, Gomes RG, Brelaz-de-Castro MCA, da Costa LAB, Pereira VRA, de Brito MEF, Dessein AJJ, Diniz GTN, Donadi EA, Lucena-Silva N.

Hum Immunol. 2019 Nov;80(11):908-916. doi: 10.1016/j.humimm.2019.08.001. Epub 2019 Aug 13.

PMID:
31420207
2.

Low plasma haptoglobin is a risk factor for life-threatening childhood severe malarial anemia and not an exclusive consequence of hemolysis.

Abah SE, Burté F, Marquet S, Brown BJ, Akinkunmi F, Oyinloye G, Afolabi NK, Omokhodion S, Lagunju I, Shokunbi WA, Wahlgren M, Dessein H, Argiro L, Dessein AJ, Noyvert B, Hunt L, Elgar G, Sodeinde O, Holder AA, Fernandez-Reyes D.

Sci Rep. 2018 Dec 3;8(1):17527. doi: 10.1038/s41598-018-35944-w.

3.

Reply to Watschinger et al.

Marquet S, Dessein AJ.

J Infect Dis. 2018 May 5;217(11):1847-1848. doi: 10.1093/infdis/jiy091. No abstract available.

PMID:
29741739
4.

Exome Sequencing Identifies Two Variants of the Alkylglycerol Monooxygenase Gene as a Cause of Relapses in Visceral Leishmaniasis in Children, in Sudan.

Marquet S, Bucheton B, Reymond C, Argiro L, El-Safi SH, Kheir MM, Desvignes JP, Béroud C, Mergani A, Hammad A, Dessein AJ.

J Infect Dis. 2017 Jul 1;216(1):22-28. doi: 10.1093/infdis/jix277.

PMID:
28586473
5.

A Functional IL22 Polymorphism (rs2227473) Is Associated with Predisposition to Childhood Cerebral Malaria.

Marquet S, Conte I, Poudiougou B, Argiro L, Dessein H, Couturier C, Burté F, Oumar AA, Brown BJ, Traore A, Afolabi NK, Barry A, Omokhodion S, Shokunbi WA, Sodeinde O, Doumbo O, Fernandez-Reyes D, Dessein AJ.

Sci Rep. 2017 Jan 31;7:41636. doi: 10.1038/srep41636.

6.

The IL17F and IL17RA Genetic Variants Increase Risk of Cerebral Malaria in Two African Populations.

Marquet S, Conte I, Poudiougou B, Argiro L, Cabantous S, Dessein H, Burté F, Oumar AA, Brown BJ, Traore A, Afolabi NK, Barry A, Omokhodion S, Ndoumbe UE, Shokunbi WA, Sodeinde O, Doumbo O, Fernandez-Reyes D, Dessein AJ.

Infect Immun. 2015 Dec 14;84(2):590-7. doi: 10.1128/IAI.00671-15. Print 2016 Feb.

7.

American tegumentary leishmaniasis: mRNA expression for Th1 and Treg mediators are predominant in patients with recent active disease.

Souza MA, Almeida TM, Castro MC, Oliveira-Mendes AP, Almeida AF, Oliveira BC, Rocha LF, Medeiros AC, Brito ME, Dessein AJ, Pereira VR.

Immunobiology. 2016 Feb;221(2):253-9. doi: 10.1016/j.imbio.2015.08.009. Epub 2015 Aug 14.

PMID:
26572279
8.

Genotype combinations of two IL4 polymorphisms influencing IL-4 plasma levels are associated with different risks of severe malaria in the Malian population.

Cabantous S, Ranque S, Poudiougou B, Traore A, Berbache S, Vitte J, Bongrand P, Doumbo O, Dessein AJ, Abel L, Marquet S.

Immunogenetics. 2015 Jun;67(5-6):283-8. doi: 10.1007/s00251-015-0836-3. Epub 2015 May 3.

PMID:
25935236
9.

IL2RA genetic variants reduce IL-2-dependent responses and aggravate human cutaneous leishmaniasis.

Oliveira PR, Dessein H, Romano A, Cabantous S, de Brito ME, Santoro F, Pitta MG, Pereira V, Pontes-de-Carvalho LC, Rodrigues V Jr, Rafati S, Argiro L, Dessein AJ.

J Immunol. 2015 Mar 15;194(6):2664-72. doi: 10.4049/jimmunol.1402047. Epub 2015 Feb 11.

10.

Factors controlling the effect of praziquantel on liver fibrosis in Schistosoma mansoni-infected patients.

Rahoud SA, Mergani A, Khamis AH, Saeed OK, Mohamed-Ali Q, Dessein AJ, Elwali NE.

FEMS Immunol Med Microbiol. 2010 Feb;58(1):106-12. doi: 10.1111/j.1574-695X.2009.00640.x. Epub 2009 Nov 30.

11.

Genetic evidence for the aggravation of Plasmodium falciparum malaria by interleukin 4.

Cabantous S, Poudiougou B, Oumar AA, Traore A, Barry A, Vitte J, Bongrand P, Marquet S, Doumbo O, Dessein AJ.

J Infect Dis. 2009 Nov 15;200(10):1530-9. doi: 10.1086/644600.

PMID:
19835477
12.

A functional promoter variant in IL12B predisposes to cerebral malaria.

Marquet S, Doumbo O, Cabantous S, Poudiougou B, Argiro L, Safeukui I, Konate S, Sissoko S, Chevereau E, Traore A, Keita MM, Chevillard C, Abel L, Dessein AJ.

Hum Mol Genet. 2008 Jul 15;17(14):2190-5. doi: 10.1093/hmg/ddn118. Epub 2008 Apr 15.

PMID:
18413324
13.

Life-threatening malaria in African children: a prospective study in a mesoendemic urban setting.

Ranque S, Poudiougou B, Traoré A, Keita M, Oumar AA, Safeukui I, Marquet S, Cabantous S, Diakité M, Mintha D, Cissé MB, Keita MM, Dessein AJ, Doumbo OK.

Pediatr Infect Dis J. 2008 Feb;27(2):130-5. doi: 10.1097/INF.0b013e31815988ed.

PMID:
18174865
14.

Identification of a novel G245R polymorphism in the IL-2 receptor beta membrane proximal domain associated with human visceral leishmaniasis.

Bucheton B, Argiro L, Chevillard C, Marquet S, Kheir MM, Mergani A, El-Safi SH, Dessein AJ.

Genes Immun. 2007 Jan;8(1):79-83. Epub 2006 Nov 16.

PMID:
17108990
15.

Alleles 308A and 238A in the tumor necrosis factor alpha gene promoter do not increase the risk of severe malaria in children with Plasmodium falciparum infection in Mali.

Cabantous S, Doumbo O, Ranque S, Poudiougou B, Traore A, Hou X, Keita MM, Cisse MB, Dessein AJ, Marquet S.

Infect Immun. 2006 Dec;74(12):7040-2. Epub 2006 Sep 18.

16.

Urinary disease in 2 Dogon populations with different exposure to Schistosoma haematobium infection: progression of bladder and kidney diseases in children and adults.

Kouriba B, Traore HA, Dabo A, Sangare L, Guindo H, Keita AS, Reimert CM, van Dam GJ, Deelder AM, Doumbo O, Dessein AJ.

J Infect Dis. 2005 Dec 15;192(12):2152-9. Epub 2005 Nov 11.

PMID:
16288382
17.

Evidence that interferon-gamma plays a protective role during cerebral malaria.

Cabantous S, Poudiougou B, Traore A, Keita M, Cisse MB, Doumbo O, Dessein AJ, Marquet S.

J Infect Dis. 2005 Sep 1;192(5):854-60. Epub 2005 Jul 22.

PMID:
16088835
18.

Familial aggregation of cerebral malaria and severe malarial anemia.

Ranque S, Safeukui I, Poudiougou B, Traoré A, Keita M, Traoré D, Diakité M, Cissé MB, Keita MM, Doumbo OK, Dessein AJ.

J Infect Dis. 2005 Mar 1;191(5):799-804. Epub 2005 Jan 27.

PMID:
15688298
19.

Antileishmanial antibodies in an outbreak of visceral leishmaniasis in eastern Sudan: high antibody responses occur in resistant subjects and are not predictive of disease.

Buchetont B, El-Safi SH, Hammad A, Kheir MM, Eudes N, Mirgani A, Dessein AJ, Mary C.

Trans R Soc Trop Med Hyg. 2003 Jul-Aug;97(4):463-8.

PMID:
15259483
20.

IFN-gamma polymorphisms (IFN-gamma +2109 and IFN-gamma +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni).

Chevillard C, Moukoko CE, Elwali NE, Bream JH, Kouriba B, Argiro L, Rahoud S, Mergani A, Henri S, Gaudart J, Mohamed-Ali Q, Young HA, Dessein AJ.

J Immunol. 2003 Nov 15;171(10):5596-601.

21.

A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar.

Bucheton B, Abel L, El-Safi S, Kheir MM, Pavek S, Lemainque A, Dessein AJ.

Am J Hum Genet. 2003 Nov;73(5):1052-60. Epub 2003 Oct 13.

22.

No evidence for a major effect of tumor necrosis factor alpha gene polymorphisms in periportal fibrosis caused by Schistosoma mansoni infection.

Moukoko CE, El Wali N, Saeed OK, Mohamed-Ali Q, Gaudart J, Dessein AJ, Chevillard C.

Infect Immun. 2003 Oct;71(10):5456-60.

23.

Contrasting cellular responses in Schistosoma haematobium infected and exposed individuals from areas of high and low transmission in Zimbabwe.

Mduluza T, Ndhlovu PD, Midzi N, Scott JT, Mutapi F, Mary C, Couissinier-Paris P, Turner CM, Chandiwana SK, Woolhouse ME, Dessein AJ, Hagan P.

Immunol Lett. 2003 Sep 8;88(3):249-56.

PMID:
12941484
24.

Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease.

Henri S, Chevillard C, Mergani A, Paris P, Gaudart J, Camilla C, Dessein H, Montero F, Elwali NE, Saeed OK, Magzoub M, Dessein AJ.

J Immunol. 2002 Jul 15;169(2):929-36.

25.

Induction of a protection against S. mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorption with GM-CSF on alum.

Argiro L, Henri S, Dessein H, Kouriba B, Dessein AJ, Bourgois A.

Vaccine. 2000 Apr 3;18(19):2033-8.

PMID:
10706966
26.

T cell clones from Schistosoma haematobium infected and exposed individuals lacking distinct cytokine profiles for Th1/Th2 polarisation.

Mduluza T, Ndhlovu PD, Midzi N, Mary C, Paris CP, Turner CM, Chandiwana SK, Woolhouse ME, Dessein AJ, Hagan P.

Mem Inst Oswaldo Cruz. 2001;96 Suppl:89-101.

27.

Genetics of parasitic infections.

Dessein AJ, Chevillard C, Marquet S, Henri S, Hillaire D, Dessein H.

Drug Metab Dispos. 2001 Apr;29(4 Pt 2):484-8.

PMID:
11259337
28.

Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH.

Argiro LL, Kohlstädt SS, Henri SS, Dessein HH, Matabiau VV, Paris PP, Bourgois AA, Dessein AJ.

Vaccine. 2000 Apr 3;18(19):2039-48.

PMID:
10706967
29.

Infection and disease in human schistosomiasis mansoni are under distinct major gene control.

Dessein AJ, Marquet S, Henri S, El Wali NE, Hillaire D, Rodrigues V, Prata A, Ali QM, Gharib B, de Reggi M, Magzoub MM, Saeed OK, Abdelhameed AA, Abel L.

Microbes Infect. 1999 Jun;1(7):561-7. Review. No abstract available.

PMID:
10603573
31.

Susceptibility to periportal (Symmers) fibrosis in human schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression.

Mohamed-Ali Q, Elwali NE, Abdelhameed AA, Mergani A, Rahoud S, Elagib KE, Saeed OK, Abel L, Magzoub MM, Dessein AJ.

J Infect Dis. 1999 Oct;180(4):1298-306.

PMID:
10479161
32.

Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes.

Rodrigues V Jr, Piper K, Couissinier-Paris P, Bacelar O, Dessein H, Dessein AJ.

Infect Immun. 1999 Sep;67(9):4689-92.

33.

Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene.

Dessein AJ, Hillaire D, Elwali NE, Marquet S, Mohamed-Ali Q, Mirghani A, Henri S, Abdelhameed AA, Saeed OK, Magzoub MM, Abel L.

Am J Hum Genet. 1999 Sep;65(3):709-21.

35.

Genetic epidemiology of infectious diseases in humans: design of population-based studies.

Abel L, Dessein AJ.

Emerg Infect Dis. 1998 Oct-Dec;4(4):593-603. Review.

36.

High prevalence of GB-C/hepatitis G virus in a Brazilian population with helminth infection.

Gallian P, Rodrigues V, Cantaloube JF, Dessein H, de Micco P, Dessein AJ, de Lamballerie X.

J Med Virol. 1998 Dec;56(4):310-5.

PMID:
9829634
37.

Linkage analysis of blood Plasmodium falciparum levels: interest of the 5q31-q33 chromosome region.

Garcia A, Marquet S, Bucheton B, Hillaire D, Cot M, Fievet N, Dessein AJ, Abel L.

Am J Trop Med Hyg. 1998 Jun;58(6):705-9.

PMID:
9660449
38.

The impact of host genetics on susceptibility to human infectious diseases.

Abel L, Dessein AJ.

Curr Opin Immunol. 1997 Aug;9(4):509-16. Review.

PMID:
9287190
39.

Characterization of a schistosome T cell-stimulating antigen (Sm10) associated with protective immunity in humans.

Kohlstädt S, Couissinier-Paris P, Bourgois A, Bouchon B, Piper K, Kolbe H, Dessein AJ.

Mol Biochem Parasitol. 1997 Feb;84(2):155-65.

PMID:
9084036
40.

Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33.

Marquet S, Abel L, Hillaire D, Dessein H, Kalil J, Feingold J, Weissenbach J, Dessein AJ.

Nat Genet. 1996 Oct;14(2):181-4.

PMID:
8841190
41.
42.

Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2.

Couissinier-Paris P, Dessein AJ.

Eur J Immunol. 1995 Aug;25(8):2295-302.

PMID:
7545117
43.

Identification of a major T cell immunogen in the anti-schistosome response of adult residents in an area endemic for Schistosoma mansoni.

Couissinier-Paris P, Bourgois A, Dessein H, Bacellar O, Rodrigues V Jr, Kohlstädt S, Buonavista N, Pène J, Dessein AJ.

Eur J Immunol. 1995 Apr;25(4):903-10.

PMID:
7737292
44.

Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.

Demeure CE, Rihet P, Abel L, Ouattara M, Bourgois A, Dessein AJ.

J Infect Dis. 1993 Oct;168(4):1000-8.

PMID:
7690821
45.

Correlation between cell-mediated immunity and degree of infection in subjects living in an endemic area of schistosomiasis.

de Jesus AM, Almeida RP, Bacellar O, Araujo MI, Demeure C, Bina JC, Dessein AJ, Carvalho EM.

Eur J Immunol. 1993 Jan;23(1):152-8.

PMID:
8419165
46.
47.

Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni.

Dessein AJ, Couissinier P, Demeure C, Rihet P, Kohlstaedt S, Carneiro-Carvalho D, Ouattara M, Goudot-Crozel V, Dessein H, Bourgois A, et al.

Immunol Invest. 1992 Aug;21(5):423-53. Review.

PMID:
1428019
48.

Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels.

Rihet P, Demeure CE, Bourgois A, Prata A, Dessein AJ.

Eur J Immunol. 1991 Nov;21(11):2679-86.

PMID:
1936116
50.

Supplemental Content

Loading ...
Support Center